Forendo Pharma Ltd.
Records under this name other than the patents Forendo Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 5 of 5 · Back to Forendo Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,891,070 | Method for the Preparation of 2-{2-[4-(4-Chloro-1,2-Diphenylbut-1-ENYL)PHENOXY]ETHOXY}ETHANOL and Its Isomers Term ended Term ended Apr 17, 2022 · High confidence | Term ended | Term ended Apr 17, 2022 | High confidence |
| US 6,875,775 | Triphenylalkene Derivatives and Their Use as Selective Estrogen Receptor Modulators Term ended Term ended Dec 29, 2020 · Medium confidence | Term ended | Term ended Dec 29, 2020 | Medium confidence |
| US 6,576,645 | Triphenylalkene derivatives and their use as selective estrogen receptor modulators Term ended Term ended Nov 15, 2020 · From the USPTO record | Term ended | Term ended Nov 15, 2020 | From the USPTO record |
| US 6,316,431 | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents Term ended Term ended Sep 19, 2020 · From the USPTO record | Term ended | Term ended Sep 19, 2020 | From the USPTO record |
| US 5,972,921 | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men Term ended Term ended no later than Oct 26, 2019 · Low confidence | Term ended | Term ended no later than Oct 26, 2019 | Low confidence |